Ventyx Biosciences Inc expected to post a loss of 92 cents a share - Earnings Preview

Ventyx Biosciences

01/11/2023 20:03

* Ventyx Biosciences Inc  VTYX.OQ   VTYX.O  is expected
to show no
change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Ventyx Biosciences
Inc is
for a loss of 92 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $53​, above​ its last closing price
of $14.42. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.72       -0.71      -0.91     Missed  -28
 Mar. 31 2023  -0.65       -0.65      -0.68     Missed  -5
 Dec. 31 2022  -0.67       -0.63      -0.62     Beat    0.8​
 Sep. 30 2022  -0.43       -0.44      -0.59     Missed  -33.7
 ​​Jun.        -0.46       -0.45      -0.39     Beat    13.3
 30 2022                                                
 Mar. 31 2022  -0.51       -0.52      -0.45     Beat    13.4​
 Dec. 31 2021  -0.32       -1.00      -0.36     Beat    64.1
 Sep. 30 2021  -0.36       -0.36      -3.17     Missed  -780.6
 This summary was machine generated November 1 at 20:03 GMT.  All
figures in US dollars  unless otherwise stated